<div id="readability-page-1"><p>Revvity Inc. (NYSE:RVTY - Get Free Report) has earned a consensus rating of &#34;Moderate Buy&#34; from the fourteen analysts that are currently  covering the stock, MarketBeat.com reports. One investment analyst  has rated the stock with a sell rating, five have issued  a hold rating and eight have assigned  a buy rating to  the company. The average 1 year price target among analysts that have updated their coverage on the stock in the last year is $114.75.</p><p>RVTY has been the subject of a number of research reports. Barclays upped their target price on shares of Revvity from $100.00 to $105.00 and gave the company an &#34;overweight&#34; rating in a report on Tuesday, October 28th. Guggenheim started coverage on shares of Revvity in a research report on Wednesday, October 15th. They set a &#34;neutral&#34; rating for the company. Evercore ISI  restated an &#34;outperform&#34; rating and issued a $108.00 price objective on shares of Revvity in a research note on Monday, October 27th. Robert W. Baird raised their target price on Revvity from $122.00 to $123.00 and gave the stock an &#34;outperform&#34; rating in a report on Tuesday, October 28th. Finally, Bank of America lowered their target price on Revvity from $110.00 to $99.00 and set a &#34;buy&#34; rating on the stock in a research report on Monday, September 22nd.</p><p><b>Read Our Latest Research Report on Revvity</b></p><h2>Hedge Funds Weigh In On Revvity</h2><p>Large investors have recently added to or reduced their stakes in the company. T. Rowe Price Investment Management Inc. increased its stake in shares of  Revvity by 8.5% in the first quarter. T. Rowe Price Investment Management Inc. now owns 22,515,711 shares of the company's stock worth $2,382,163,000 after purchasing an additional 1,754,403 shares in the last quarter.  Vanguard Group Inc. boosted its holdings in  Revvity by 0.6% in the 1st quarter. Vanguard Group Inc. now owns 14,382,849 shares of the company's stock worth $1,521,705,000 after buying an additional 92,638 shares during the period.  Price T Rowe Associates Inc. MD boosted its holdings in  Revvity by 25.3% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 9,563,911 shares of the company's stock worth $1,011,863,000 after buying an additional 1,932,314 shares during the period.  EdgePoint Investment Group Inc. increased its stake in  Revvity by 26.3% in the 3rd quarter. EdgePoint Investment Group Inc. now owns 8,574,280 shares of the company's stock worth $751,536,000 after buying an additional 1,784,620 shares in the last quarter.  Finally, Invesco Ltd. raised its holdings in  Revvity by 15.7% during the third quarter. Invesco Ltd. now owns 2,553,515 shares of the company's stock valued at $223,816,000 after acquiring an additional 346,313 shares during the period. Hedge funds and other institutional investors own  86.65% of the company's stock. </p><h2>Revvity Stock Down 1.7%</h2><p>RVTY stock opened at $100.81 on Friday. The company has a market cap of $11.43 billion, a price-to-earnings ratio of 50.66, a P/E/G ratio of 3.39 and a beta of 1.06. The company has a debt-to-equity ratio of 0.36, a quick ratio of 1.44 and a current ratio of 1.75. The business's 50-day moving average is $95.01 and its two-hundred day moving average is $92.97. Revvity has a fifty-two week low of $81.36 and a fifty-two week high of $128.29. </p><p>Revvity (NYSE:RVTY - Get Free Report) last released its quarterly earnings results on Monday, October 27th. The company reported $1.18 EPS for the quarter, beating the consensus estimate of $1.14 by $0.04. Revvity had a net margin of 8.44% and a return on equity of 7.52%. The firm had revenue of $698.95 million during the quarter, compared to analyst estimates of $699.75 million. During the same quarter in the prior year, the firm earned $1.28 EPS. The business's revenue for the quarter was up 2.2% compared to the same quarter last year. Revvity has set its FY 2025 guidance at 4.900-5.000 EPS.  As a group, analysts forecast that  Revvity will post 4.94 earnings per share for the current year. </p><h2>Revvity Announces Dividend</h2><p>The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 6th. Investors of record on Friday, January 16th will be paid a dividend of $0.07 per share. The ex-dividend date is Friday, January 16th. This represents a $0.28 dividend on an annualized basis and a dividend yield of 0.3%. Revvity's payout ratio is 14.07%. </p><p>Revvity announced that its board has initiated a stock buyback program on Monday, October 27th that permits the company to repurchase $1.00 billion in    shares. This repurchase authorization permits the company to purchase up to 8.7% of its shares through open market purchases. Shares repurchase programs are generally a sign that the company's management believes its stock is undervalued. </p><h2>Revvity Company Profile</h2> (Get Free Report)<p>Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.</p><h2>See Also</h2><ul><li>Five stocks we like better than Revvity</li><li>Uptrend Stocks Explained: Learn How to Trade Using Uptrends</li><li>Rocket Lab’s Big Rebound? Analysts Suggest the Dip's a Gift</li><li>Why Invest in 5G? How to Invest in 5G Stocks  </li><li>Meta’s AI Moment? New SAM 3 Model Has Wall Street Turning Bullish</li><li>Most Volatile Stocks, What Investors Need to Know</li><li>Snowflake Stock: The Dip That Smart Investors Are Buying Right Now</li></ul><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVJWVFk?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="600" height="385" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVJWVFk"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Revvity Right Now?</h2><p>Before you consider Revvity, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Revvity wasn't on the list.</p><p>While Revvity currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

RVTY

<p>Revvity Inc. (NYSE:RVTY) has a consensus "Moderate Buy" rating from 14 analysts, with an average price target of $114.75. Recent analyst actions include Barclays raising its target to $105 and Robert W. Baird to $123. The stock opened at $100.81, with a market cap of $11.43 billion. Revvity reported Q3 earnings of $1.18 per share, beating estimates. The company announced a $1 billion stock buyback program.</p>

Revvity Inc. (NYSE:RVTY) Given Consensus Rating of "Moderate Buy" by Analysts